"Instytut Centrum Zdrowia Matki Polki – ICZMP w Łodzi jest jednym z największych wysokospecjalistycznych ośrodków medycznych w Polsce. Placówka składa się z dwóch części: Ginekologiczno-Położniczej oraz Pediatrycznej. Jest wiodącym ośrodkiem referencyjnym perinatologicznym, ginekologicznym i pediatrycznym. Ze względu na swój wielodyscyplinarny charakter, zapewnia wszechstronną opiekę nad kobietami w ciąży powikłanej cukrzycą, nadciśnieniem tętniczym, padaczką, chorobami serca, czy infekcjami. W Instytucie diagnozowane i leczone są najtrudniejsze przypadki patologii ginekologicznych."

During the past decade, Instytut "Centrum Zdrowia Matki Polki; Klinika Pediatrii i Immunologii i Nefrologii conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instytut "Centrum Zdrowia Matki Polki; Klinika Pediatrii i Immunologii i Nefrologii" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Instytut "Centrum Zdrowia Matki Polki; Klinika Pediatrii i Immunologii i Nefrologii" are "Atypical Hemolytic Uremic Syndrome" (2 trials), "Anemia" (1 trials) and "Renal Insufficiency, Chronic" (1 trials). Many other conditions were trialed in "Instytut "Centrum Zdrowia Matki Polki; Klinika Pediatrii i Immunologii i Nefrologii" in a lesser frequency.

Most popular intervention types in "Instytut "Centrum Zdrowia Matki Polki; Klinika Pediatrii i Immunologii i Nefrologii" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Crovalimab" (2 trials) and "Mircera" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instytut "Centrum Zdrowia Matki Polki; Klinika Pediatrii i Immunologii i Nefrologii" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Instytut "Centrum Zdrowia Matki Polki; Klinika Pediatrii i Immunologii i Nefrologii". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Instytut "Centrum Zdrowia Matki Polki; Klinika Pediatrii i Immunologii i Nefrologii, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instytut "Centrum Zdrowia Matki Polki; Klinika Pediatrii i Immunologii i Nefrologii, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".